logo

Authentidate (ADAT): Exploding Demand for Shares
By: Financial Alchemist   Sunday, July 27, 2008 7:47 PM

"The telemedicine market is a large market that we believe will benefit from our document management capabilities.  By entering this market through a joint venture, we will be able to strongly penetrate an emerging market, while expanding the use of our platform within the health care community.

ExpressMD Signs First Contract with Cyntrist:

On July 8th, it was announced that Authentidate and EncounterCare had signed their first user contract with Cyntrist, for use in remote monitoring of Diabetes patients located through out the Southeastern U.S.  The opportunity in the Diabetes space is colossal. In a recent study, the CDC reported that 24 million Americans (8% of population) are afflicted by Diabetes, a number which has increased by more than 3 million in just two years. The ExpressMD solution provides physicians with the ability to remotely monitor patients’ glucose levels, weight, etc. on a daily basis and adjust treatment as needed. Not only does this enhance the quality of patient care, it reduces the need for regular office visits, thus reducing the cost of medical care. The advantages are compelling, and with such a large addressable market, ADAT may benefit substantially.

Conclusion:

The recent news comes after Authentidate management had stated that they believed cash flow break-even could be attained by CQ1 2009. The implication was that existing business was likely sufficient to attain that goal, for it was an issue of customers ramping up implementation. Now, with these recent developments regarding the ExpressMD joint venture, Authentidate’s prospects have become even brighter.


<< Previous Page12  

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Advertisement

Related Press Releases
Popular Articles
Advertisement
Special Offers
Recent Articles by Financial Alchemist




Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia